Head|to|Head Comparison of 68Ga|PSMA|11 PET/CT and 99mTc ...

Head-To-Head Comparison of 68 Ga-PSMA-11 PET/CT ... - PubMed

On a per-patient basis, the diagnostic performance of 68Ga-PSMA-11 PET/CT is superior to that of 99mTc-MDP BS for the detection of PCa bone metastases.

Head-To-Head Comparison of 68 Ga-PSMA-11 PET/CT and 99m Tc ...

68 Ga-PSMA-11 PET/CT offers superior performance compared with 99m Tc-MDP bone scintigraphy for detecting prostate cancer bone metastases.

Head-to-head comparison of 68Ga-PSMA-11 PET with 99mTc-MDP ...

Background: 68Ga-PSMA-11 PET/CT (PSMA-PET) was approved by the U.S. Food and Drug Administration in patients with prostate cancer (PCa) at ...

Head to head comparison performance of 99mTc-EDDA/HYNIC ...

Tc-HYNIC-PSMA SPECT/CT is semi-quantitatively comparable with 68Ga-PSMA PET/CT in both the primary tumor and metastases from bone and lymph nodes. SUVmax and ...

Head-to-head comparison of 68Ga-PSMA-11 PET with 99mTc-MDP ...

Head-to-head comparison of 68Ga-PSMA-11 PET with 99mTc-MDP bone scan for detection of bone disease in prostate cancer patients with biochemical ...

A Comparison of 68Ga-PSMA-11 and 99mTc-MIP-1404 in ...

Results: 99mTc-MIP-1404 SPECT lesion SUVmax was not significantly different from 68Ga-PSMA-11 PET (median, 18.2 vs. 17.3; P = 0.93). However, ...

Comparison of 99m Tc-PSMA SPECT/CT and 68 Ga-PSMA PET/CT ...

While 68Ga PSMA is a generator-derived PET radiopharmaceutical, SPECT/CT imaging using technetium-99m-labeled PSMA is now available as a ...

Head-to-head comparison of 99m Tc-PSMA and 99m Tc-MDP ...

Tc-PSMA SPECT/CT was superior to 99mTc-MDP SPECT/CT in the detection of bone metastases in PCa, especially for small lesions and in patients ...

Comparison of hybrid 68 Ga-PSMA-PET/CT and 99m Tc-DPD ...

In the patient based analysis, accuracies measured as “area-under-the-curve” (AUC) for 68Ga-PSMA-PET, 99mTc-SPECT, 68Ga-PSMA-PET/CT and 99mTc- ...

The diagnostic accuracy of 68Ga-PSMA PET/CT versus 99mTc-MDP ...

Across all measures of accuracy, 68Ga PSMA PET/CT was superior to 99mTc-MDP bone scintigraphy in the detection of skeletal metastases. Patient-based ...

Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and 99mTc ...

Download Citation | Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and 99mTc-MDP Bone Scintigraphy for the Detection of Bone Metastases in ...

Direct comparison of 99mTc-PSMA SPECT/CT and 68Ga-PSMA ...

Objective(s): 99mTc-PSMA SPECT/CT is a cost effective alternative for 68Ga-PSMA PET/CT. The aim of this study was to directly compare these two techniques ...

A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 ...

In patients with advanced prostate cancer, [68Ga]Ga-PSMA-11 PET/CT may detect more lesions than [68Ga]Ga-NODAGAZOL PET/CT and [99mTc]Tc-MDP bone ...

Direct comparison of 99mTc-PSMA SPECT/CT and 68Ga-PSMA ...

The aim of this study was performing a head to head comparison of 68Ga-PSMA PET/CT scan with 99mTc-. PSMA SPECT/CT in a group of patients ...

(PDF) Direct comparison of 99mTc-PSMA SPECT/CT and 68Ga ...

... A head-to-head comparison of the 99m Tc-PSMA single-photon emission CT (SPECT)/CT and 68 Ga-PSMA PET/CT ...

Added value of 68 Ga-PSMA PET/CT for the detection of bone ...

... head-to-head comparison to 11-min SPECT/CT. EJNMMI Res. 2017;7:1 ... A prospective study comparing (99m)Tc-hydroxyethylene ...

Diagnostic efficacy of [99mTc]Tc-PSMA SPECT/CT for prostate cancer

In particular, [99mTc]Tc-PSMA SPECT/CT showed a higher specificity and positive likelihood ratio than [68Ga]Ga-PSMA PET/CT, while its ...

Diagnostic Performance of 99m Tc-iPSMA SPECT/CT in the Initial ...

During the last decade, PSMA-targeted positron emission tomography (PET) has become a substantial part of the imaging of prostate cancer. It has demonstrated ...

Comparing 99m Tc-PSMA to 99m Tc-MDP in Prostate Cancer ...

Tc-MDP bone scintigraphy is the cornerstone of skeletal nuclear medicine imaging and has been regarded as the standard of reference in detection of bone ...

11C-Acetate-PET/CT Compared to 99mTc-HDP Bone Scintigraphy ...

Agreement between ACE-PET/CT and follow-up was excellent (kappa coefficient of 0.95). Therapy was changed in 11% of patients due to ACE-PET/CT results.